PharmaResearch Co., Ltd. (214450.KQ)
KRW 259500.0
(2.77%)
KRW 259500.0
(2.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 261.01 Billion | 194.75 Billion | 154.08 Billion | 108.74 Billion | 83.87 Billion | 64.28 Billion |
| Cost of Revenue | 78.75 Billion | 60.62 Billion | 52.09 Billion | 41.24 Billion | 38.65 Billion | 30.32 Billion |
| Gross Profit | 182.25 Billion | 134.12 Billion | 101.98 Billion | 67.5 Billion | 45.21 Billion | 33.96 Billion |
| Operating Expenses | 89.44 Billion | 68.21 Billion | 49.49 Billion | 34.07 Billion | 26.14 Billion | 25.67 Billion |
| Selling, General and Administrative Expenses | 74.41 Billion | 58.86 Billion | 42.44 Billion | 28.29 Billion | 20.95 Billion | 21.02 Billion |
| Research and Development Expenses | 15.03 Billion | 8.7 Billion | 6.73 Billion | 5.54 Billion | 5.61 Billion | 4.04 Billion |
| Other Expenses | - | -648.64 Million | -313.54 Million | -240.17 Million | 418.95 Million | -609.02 Million |
| Cost and Expenses | 160.19 Billion | 128.84 Billion | 101.59 Billion | 75.32 Billion | 64.8 Billion | 55.99 Billion |
| Operating Income | 100.81 Billion | 65.91 Billion | 52.48 Billion | 33.42 Billion | 19.06 Billion | 8.28 Billion |
| Interest Expense | 2.98 Billion | 3.83 Billion | 1.31 Billion | 1.78 Billion | 2.34 Billion | 803.64 Million |
| Income Tax Expense | 23.43 Billion | 10.61 Billion | 9.2 Billion | 7.08 Billion | 3.67 Billion | 3.09 Billion |
| Earnings before Tax | 100.7 Billion | 56.86 Billion | 55.36 Billion | 36.36 Billion | 19.5 Billion | 14.36 Billion |
| Net Income | 76.55 Billion | 40.57 Billion | 46.68 Billion | 32.77 Billion | 16.66 Billion | 14.4 Billion |
| Earnings Per Share Basic | 7502.00 | 4067.47 | 4716.62 | 3447.46 | 1766.04 | 1527.72 |
| Earnings Per Share Diluted | 7249.68 | 4067.47 | 4714.88 | 3447.46 | 1766.04 | 1472.61 |
| Weighted Average Shares Outstanding | 10.2 Million | 9.97 Million | 9.89 Million | 9.5 Million | 9.43 Million | 9.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.55 Million | 9.97 Million | 10.05 Million | 9.5 Million | 9.43 Million | 9.78 Million |
| Gross Margin | 0.70 | 0.69 | 0.66 | 0.62 | 0.54 | 0.53 |
| EBIT Margin | 0.40 | 0.39 | 0.40 | 0.38 | 0.32 | 0.21 |
| Profit Margin | 0.29 | 0.21 | 0.30 | 0.30 | 0.20 | 0.22 |
| EBITDA | 104.25 Billion | 76.51 Billion | 66.21 Billion | 41.78 Billion | 29.53 Billion | 20.18 Billion |
| Earnings Before Tax Margin | 0.39 | 0.34 | 0.34 | 0.31 | 0.23 | 0.13 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 83.1 Billion | 74.71 Billion | 69.96 Billion | 261.01 Billion | 68.8 Billion | 66.79 Billion |
| Cost of Revenue | 25.88 Billion | 25.04 Billion | 22.66 Billion | 78.75 Billion | 20.21 Billion | 18.91 Billion |
| Gross Profit | 57.22 Billion | 49.67 Billion | 47.29 Billion | 182.25 Billion | 48.58 Billion | 47.88 Billion |
| Operating Expenses | 26.46 Billion | 23 Billion | 26.92 Billion | 89.99 Billion | 21.09 Billion | 24.23 Billion |
| Selling, General and Administrative Expenses | 20.85 Billion | 18.56 Billion | 22.02 Billion | - | 17.78 Billion | 20.1 Billion |
| Research and Development Expenses | 5.48 Billion | 4.35 Billion | 4.83 Billion | - | 3.05 Billion | 3.94 Billion |
| Other Expenses | -125.5 Million | -83.36 Million | -58.82 Million | -556.23 Million | -251.65 Million | -188.83 Million |
| Cost and Expenses | 52.34 Billion | 48.04 Billion | 49.58 Billion | 168.75 Billion | 41.31 Billion | 43.15 Billion |
| Operating Income | 30.76 Billion | 26.66 Billion | 20.37 Billion | 92.25 Billion | 27.49 Billion | 23.64 Billion |
| Interest Expense | - | 755.53 Million | 500.99 Million | 2.98 Billion | 486.45 Million | 738.39 Million |
| Income Tax Expense | 9.23 Billion | 4.95 Billion | 4.75 Billion | 23.43 Billion | 6.09 Billion | 8.09 Billion |
| Earnings before Tax | 35.38 Billion | 19.89 Billion | 19.89 Billion | 100.02 Billion | 33.36 Billion | 24.84 Billion |
| Net Income | 31.38 Billion | 17.24 Billion | 15.4 Billion | 76.55 Billion | 26.7 Billion | 16.73 Billion |
| Earnings Per Share Basic | 3058.13 | 1690.49 | 1510.37 | - | 2675.04 | 1664.31 |
| Earnings Per Share Diluted | 2506.16 | 1681.58 | 1510.37 | - | 2583.50 | 1624.54 |
| Weighted Average Shares Outstanding | 10.26 Million | 10.2 Million | 10.2 Million | 10.11 Million | 9.98 Million | 10.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.56 Million | 10.56 Million | 10.2 Million | 10.55 Million | 10.54 Million | 10.62 Million |
| Gross Margin | 0.69 | 0.66 | 0.68 | 0.70 | 0.71 | 0.72 |
| EBIT Margin | 0.41 | 0.40 | 0.34 | - | 0.44 | 0.40 |
| Profit Margin | 0.38 | 0.23 | 0.22 | 0.29 | 0.39 | 0.25 |
| EBITDA | 33.9 Billion | 29.82 Billion | 23.52 Billion | - | 30.55 Billion | 26.6 Billion |
| Earnings Before Tax Margin | 0.37 | 0.36 | 0.29 | 0.35 | 0.40 | 0.35 |
TMICY
0HCT
USBN
LPLA
002790
GSBC